Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced the close of an oversubscribed $325 million Series C financing round.
Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, secures $90 million in series...
Global Spatial Technology Solutions (“GSTS” or “the Company”), a leader in maritime innovation, secures an undisclosed amount in series A round funding from lead...
Codeium, a Mountain View, CA-based provider of an AI-powered code acceleration platform, secures $150million in series C round funding, at $1.25 Billion valuation. The...
NYC-based Comun, a Latino-founded neobank that provides modern banking solutions to immigrants1 in the U.S., has raised $21.5 million in Series A funding round led by Redpoint Ventures with participation from ANIMO Ventures, Costanoa Ventures, FJ Labs, RTP Global, and South Park Commons.
Apricus Generation, a rapidly growing holding company focused on building a national distributed solar and battery development platform and Independent Power Producer (IPP), announced the closing of its Series A funding round led by Blue Marlin Partners and Current Yield with Participation (CYwP) Fund.
nOps, the leading AWS cost optimization platform, has raised $30 million Series A funding round led by Headlight Partners. nOps is empowering organizations across the globe to solve one of the largest IT challenges of the last decade - better understanding, controlling and reducing cloud spend.
CA-based Bland AI, the platform automating phone calls for the enterprise using hyper-realistic AI agents, emerged from stealth with a $16 million Series A financing round led by Scale Venture Partners.
Planera, a construction CPM scheduling and planning solution, today announced that it has raised $13.5 million in a Series A funding round led by Sierra Ventures, with participation from Sorenson Capital, Brick and Mortar Ventures, Prudence VC and Firebolt Ventures.
ZBiotics, the pioneers carving a new category of genetically engineered probiotics, has raised $12 million in Series A funding round led by Spring Tide Capital with participation by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures.
